Copyright
©The Author(s) 2016.
World J Diabetes. Mar 10, 2016; 7(5): 74-88
Published online Mar 10, 2016. doi: 10.4239/wjd.v7.i5.74
Published online Mar 10, 2016. doi: 10.4239/wjd.v7.i5.74
Figure 2 Change in high-density lipoprotein cholesterol following fibrate treatment stratified by pre-treatment high-density lipoprotein cholesterol concentrations in 248 patients (adapted from Ramachandran et al[86]) - permission received via Rightslink.
HDL-C: High density lipoprotein cholesterol.
- Citation: Shipman KE, Strange RC, Ramachandran S. Use of fibrates in the metabolic syndrome: A review. World J Diabetes 2016; 7(5): 74-88
- URL: https://www.wjgnet.com/1948-9358/full/v7/i5/74.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i5.74